Technical Analysis for CLYYF - Celyad Sa

Grade Last Price % Change Price Change
grade C 12.24 8.80% 0.9900
CLYYF closed up 8.8 percent on Wednesday, January 22, 2020, on 1.85 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A N/A
Historical CLYYF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Gapped Up Strength 0.00%
New 52 Week Closing Low Bearish 8.80%
Hot IPO Pullback Bullish Swing Setup 8.80%
Narrow Range Bar Range Contraction 8.80%
New 52 Week Low Weakness 8.80%
Down 3 Days in a Row Weakness 8.80%
Gapped Down Weakness 8.80%
New 52 Week Closing Low Bearish 8.32%
Hot IPO Pullback Bullish Swing Setup 8.32%
Older signals for CLYYF ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Celyad SA, a clinical-stage biopharmaceutical company, focuses on the development of CAR-T cell-based therapies. The company utilizes its expertise in cell engineering to target cancer. Its CAR-T cell platform has the potential to treats a range of solid and hematologic tumors. The company's lead drug product candidate, CYAD-01 (CAR-T NKG2D), has been evaluated in a Phase I clinical trial to assess the safety and clinical activity of multiple administrations of autologous CYAD-01 cells in seven refractory cancers, including five solid tumors, such as colorectal, ovarian, bladder, triple-negative breast, and pancreatic cancers; and two hematological tumors comprising acute myeloid leukemia and multiple myeloma. The company was formerly known as Cardio3 BioSciences SA and changed its name to Celyad SA in May 2015. Celyad SA was founded in 2004 and is based in Mont-Saint-Guibert, Belgium.
Cancer Biopharmaceutical Solid Tumors Monoclonal Antibodies Acute Myeloid Leukemia Multiple Myeloma Virotherapy Pancreatic Cancers Hematological Tumors

Is CLYYF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 27.3
52 Week Low 11.25
Average Volume 325
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 0.0000
10-Day Moving Average 0.0000
Average True Range 0.0000
ADX 0.0
+DI 0.0000
-DI 0.0000
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0000
Lower Bollinger Band 0.0000
Percent B (%b) 0.0
BandWidth 0.0000
MACD Line 0.0000
MACD Signal Line 0.0000
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.2400
Resistance 3 (R3) 12.2400 12.2400 12.2400
Resistance 2 (R2) 12.2400 12.2400 12.2400 12.2400
Resistance 1 (R1) 12.2400 12.2400 12.2400 12.2400 12.2400
Pivot Point 12.2400 12.2400 12.2400 12.2400 12.2400
Support 1 (S1) 12.2400 12.2400 12.2400 12.2400 12.2400
Support 2 (S2) 12.2400 12.2400 12.2400 12.2400
Support 3 (S3) 12.2400 12.2400 12.2400
Support 4 (S4) 12.2400